Tuesday, 02 January 2024 12:17 GMT
عربي


               US          Europe          Arab          Asia          Africa    
|      Politics          Economy     Oil&Energy         
                 Entertainment          Sport
Oncolytics Biotech Inc

Oncolytics Biotech Inc


2026-01-07 03:13:56
(MENAFN- Baystreet) 11:31 AM EST - Oncolytics Biotech Inc: Announced the expansion of its gastrointestinal Tumor Scientific Advisory Board with the appointment of Dr. Eileen O'Reilly, Dr. Neil Segal, and Dr. Van Morris, three globally recognized experts in gastrointestinal oncology. The GI SAB was recently established to support Oncolytics' growing portfolio of clinical programs in pancreatic, colorectal, and anal cancers and to guide the Company's strategy as it advances pelareorep as a platform immunotherapy across GI tumors. Oncolytics Biotech Inc shares N are trading up $0.03 at $0.99.

Full Press Release:

MENAFN07012026000212011056ID1110569650



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Tags

Label

Comments

No comment

Category

Date
Search